Prognosis of patients suffering from hyperleukocytosis is dependent on the cause and type of leukemia the patient has. Patients diagnosed with asymptomatic hyperleukocytosis have significantly better survival rates than symptomatic hyperleukocytosis<unk> . Preventative measures and contentious monitoring of patients diagnosed with leukemia is critical in receiving treatment as early as possible to prevent and treat hyperleukocytosis.
Leukostasis
Vasospasm
Leukocytosis
Thrombocytopenia
Allostasis
Cytotoxicity
Cytopenia
Lipotoxicity